title: Prenatal diagnosis of fragile X syndrome: (CGG)n expansion and methylation of chorionic villus samples.
abstract: Fragile X syndrome is the most common form of inherited mental retardation, due to an expansion of the (CGG)n trinucleotide repeat in the FMR-1 gene and hypermethylation of its 5' upstream CpG island. Two major problems remain to be resolved for fragile X prenatal diagnosis: the abnormal methylation patterns of chorionic villus samples (CVS) and the inability to predict the mental status of females with the full mutation. We present here the results of ten prenatal diagnoses of fragile X syndrome using Southern blotting and polymerase chain reaction (PCR) amplification, and the analysis of 50 further CVS to test the methylation status of the CpG island of the FMR-1 gene. In the ten 'at-risk' CVS, eight normal (five males and three females) and two affected male fetuses were detected. Absence of methylation in the CVS was observed in two cases, which was not found upon subsequent examination of the newborn or of fetal tissues. In the 50 CVS not 'at risk' for fragile X syndrome, abnormal fragment patterns for probe StB12.3 were detected in 32 per cent for female and 24 per cent for male fetuses. This abnormal pattern could be due to absent or partial methylation of the CpG island of the FMR-1 gene in chorionic villus tissues.
authors.affiliation: Servei de Genètica, Hospital Clínic, Barcelona, Catalunya, Spain.
authors.forename: S
authors.initials: S
authors.lastname: Castellví-Bel
authors.forename: M
authors.initials: M
authors.lastname: Milà
authors.forename: A
authors.initials: A
authors.lastname: Soler
authors.forename: A
authors.initials: A
authors.lastname: Carrió
authors.forename: A
authors.initials: A
authors.lastname: Sánchez
authors.forename: M
authors.initials: M
authors.lastname: Villa
authors.forename: M D
authors.initials: MD
authors.lastname: Jiménez
authors.forename: X
authors.initials: X
authors.lastname: Estivill
mesh_terms: D015139:Blotting, Southern; D015193:Chorionic Villi Sampling; D018899:CpG Islands; D005260:Female; D051860:Fragile X Messenger Ribonucleoprotein 1; D005600:Fragile X Syndrome / Q000175:diagnosis* / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D008297:Male; D008745:Methylation; D009154:Mutation; D009419:Nerve Tissue Proteins / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011247:Pregnancy; D018566:Pregnancy, High-Risk; D016601:RNA-Binding Proteins; D012091:Repetitive Sequences, Nucleic Acid
chemical_list: D051860:Fragile X Messenger Ribonucleoprotein 1; D009419:Nerve Tissue Proteins; D016601:RNA-Binding Proteins; C497683:FMR1 protein, human